JP2007277257A5 - - Google Patents

Download PDF

Info

Publication number
JP2007277257A5
JP2007277257A5 JP2007158916A JP2007158916A JP2007277257A5 JP 2007277257 A5 JP2007277257 A5 JP 2007277257A5 JP 2007158916 A JP2007158916 A JP 2007158916A JP 2007158916 A JP2007158916 A JP 2007158916A JP 2007277257 A5 JP2007277257 A5 JP 2007277257A5
Authority
JP
Japan
Prior art keywords
piperidinyl
dihydro
benzamidazol
oxo
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007158916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007277257A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2007277257A publication Critical patent/JP2007277257A/ja
Publication of JP2007277257A5 publication Critical patent/JP2007277257A5/ja
Pending legal-status Critical Current

Links

JP2007158916A 1999-12-06 2007-06-15 ノシセプチン受容体親和性を有するベンズイミダゾール化合物 Pending JP2007277257A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16939499P 1999-12-06 1999-12-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001541507A Division JP2003524634A (ja) 1999-12-06 2000-12-06 ノシセプチン受容体親和性を有するベンズイミダゾール化合物

Publications (2)

Publication Number Publication Date
JP2007277257A JP2007277257A (ja) 2007-10-25
JP2007277257A5 true JP2007277257A5 (cg-RX-API-DMAC7.html) 2007-12-20

Family

ID=22615490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001541507A Pending JP2003524634A (ja) 1999-12-06 2000-12-06 ノシセプチン受容体親和性を有するベンズイミダゾール化合物
JP2007158916A Pending JP2007277257A (ja) 1999-12-06 2007-06-15 ノシセプチン受容体親和性を有するベンズイミダゾール化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001541507A Pending JP2003524634A (ja) 1999-12-06 2000-12-06 ノシセプチン受容体親和性を有するベンズイミダゾール化合物

Country Status (8)

Country Link
US (2) US7456198B2 (cg-RX-API-DMAC7.html)
EP (1) EP1242085B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003524634A (cg-RX-API-DMAC7.html)
AT (1) ATE302770T1 (cg-RX-API-DMAC7.html)
AU (1) AU1816901A (cg-RX-API-DMAC7.html)
DE (1) DE60022226D1 (cg-RX-API-DMAC7.html)
HK (1) HK1049284B (cg-RX-API-DMAC7.html)
WO (1) WO2001039775A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1816901A (en) * 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity
IL158484A0 (en) * 2001-04-18 2004-05-12 Euro Celtique Sa Nociceptin analogs
CA2465328C (en) * 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
JP4056977B2 (ja) 2002-03-29 2008-03-05 田辺三菱製薬株式会社 睡眠障害治療薬
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
DE10252666A1 (de) * 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
AR045939A1 (es) 2003-09-25 2005-11-16 Solvay Pharm Bv Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos
AR045843A1 (es) 2003-10-03 2005-11-16 Solvay Pharm Bv Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos
KR100886002B1 (ko) 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법
UA83919C2 (en) * 2004-04-20 2008-08-26 Санофи Авентис Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
US7300947B2 (en) * 2005-07-13 2007-11-27 Banyu Pharmaceutical Co., Ltd. N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
AR054816A1 (es) * 2005-07-13 2007-07-18 Banyu Pharma Co Ltd Derivados de n-dihidroxialquil 2-oxo- imidazol sustituidos
WO2007037513A1 (ja) * 2005-09-30 2007-04-05 Banyu Pharmaceutical Co., Ltd. アリール置換含窒素複素環化合物
US20080015214A1 (en) * 2005-10-24 2008-01-17 Bignan Gilles C 3-piperidin-4-yl-indole orl-1 receptor modulators
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス.エイ. カルシウムチャネルブロッカーとしての環状尿素化合物
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
US8775704B2 (en) * 2006-04-05 2014-07-08 Nvidia Corporation Method and system for communication between a secondary processor and an auxiliary display subsystem of a notebook
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
EP2397477B1 (en) * 2007-01-16 2014-03-05 Purdue Pharma LP Heterocyclic-substituted piperidine compounds and the uses thereof
BRPI0808025A2 (pt) * 2007-03-01 2014-06-24 Mitsubishi Tanabe Pharma Corp Composto de benzimidazol e uso farmacêutico do mesmo
RU2451017C2 (ru) * 2007-03-01 2012-05-20 Мицубиси Танабе Фарма Корпорейшн Бензимидазольное соединение и его фармацевтическое применение
MY150602A (en) 2007-08-31 2014-01-30 Purdue Pharma Lp Subtituted-quinoxaline-type piperidine compounds and the uses thereof
WO2009124883A1 (en) * 2008-04-09 2009-10-15 H. Lundbeck A/S Novel 1,3-dihydro-benzoimidazol-2-ones as m1 agonists
KR101333660B1 (ko) 2008-07-21 2013-11-27 시오노기세이야쿠가부시키가이샤 치환-퀴녹살린-형 가교-피페리딘 화합물 및 그의 용도
US8736617B2 (en) * 2008-08-04 2014-05-27 Nvidia Corporation Hybrid graphic display
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
US9075559B2 (en) * 2009-02-27 2015-07-07 Nvidia Corporation Multiple graphics processing unit system and method
US9135675B2 (en) * 2009-06-15 2015-09-15 Nvidia Corporation Multiple graphics processing unit display synchronization system and method
US8766989B2 (en) * 2009-07-29 2014-07-01 Nvidia Corporation Method and system for dynamically adding and removing display modes coordinated across multiple graphics processing units
US8780122B2 (en) * 2009-09-16 2014-07-15 Nvidia Corporation Techniques for transferring graphics data from system memory to a discrete GPU
US9111325B2 (en) * 2009-12-31 2015-08-18 Nvidia Corporation Shared buffer techniques for heterogeneous hybrid graphics
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014102588A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9818379B2 (en) 2013-08-08 2017-11-14 Nvidia Corporation Pixel data transmission over multiple pixel interfaces
US20240287019A1 (en) * 2021-06-07 2024-08-29 Kinki University T-type calcium channel blocker
CN121843930A (zh) * 2024-01-05 2026-04-10 宜昌人福药业有限责任公司 一种环己基取代哌啶衍生物、包含其的药物组合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (cg-RX-API-DMAC7.html) * 1962-06-13
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
GR69650B (cg-RX-API-DMAC7.html) * 1978-07-20 1982-07-07 Science Union & Cie
US4329353A (en) * 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
EP0974583B1 (en) 1995-09-13 2002-05-29 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidine derivatives
US6180649B1 (en) * 1996-04-19 2001-01-30 Nerosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
ES2226129T3 (es) 1997-05-30 2005-03-16 Banyu Pharmaceutical Co., Ltd. Derivados de 2-0x0imidazol.
SI0921125T1 (en) 1997-12-05 2002-04-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
AU1679099A (en) * 1998-01-19 1999-08-02 Pfizer Inc. 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
NZ507760A (en) 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists
AU3809999A (en) 1998-05-18 1999-12-06 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
AU1816901A (en) * 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity

Similar Documents

Publication Publication Date Title
JP2007277257A5 (cg-RX-API-DMAC7.html)
JP2009534470A5 (cg-RX-API-DMAC7.html)
JP2013528180A5 (cg-RX-API-DMAC7.html)
RU2013150083A (ru) Новое пиразольное производное
AR124662A2 (es) Formulaciones inmunosupresoras
JP2010265321A5 (cg-RX-API-DMAC7.html)
JP2009530345A5 (cg-RX-API-DMAC7.html)
JP2009533343A5 (cg-RX-API-DMAC7.html)
JP2008195730A5 (cg-RX-API-DMAC7.html)
JP2010507602A5 (cg-RX-API-DMAC7.html)
JP2011517453A5 (cg-RX-API-DMAC7.html)
JP2009535358A5 (cg-RX-API-DMAC7.html)
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
RU2006132463A (ru) Антагонисты рецептора хемокина
AR074089A1 (es) Antagonistas de cicloalcano (b) azaindol de los receptores de la postaglandina d2
PE20091818A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
JP2012533546A5 (cg-RX-API-DMAC7.html)
EP2669271A1 (en) Indole derivative, and pharmacologically acceptable salt thereof
JP2009538358A5 (cg-RX-API-DMAC7.html)
JP2013530942A5 (cg-RX-API-DMAC7.html)
JP2010155827A5 (cg-RX-API-DMAC7.html)
JP2009541209A5 (cg-RX-API-DMAC7.html)
JP2014532728A5 (cg-RX-API-DMAC7.html)
CN104151292A (zh) 吲哚衍生物或其可药用盐